{
  "Clinical Information": [],
  "Patent Information": [],
  "Sequence Information": {
    "ID": "AP04774",
    "Peptide Name": "WL-1 (Synthetic AMPs, GF-17 analog, UCLL1)",
    "Source": "amino acid substitution, human cathelicidin analog, animal-derived, natural derivative",
    "Family": "Not found",
    "Gene": "Not found",
    "Sequence": "GWKRIKQRIKDKLRNL",
    "Sequence Length": 16,
    "UniProt Entry": "Ref",
    "Protein Existence": "Not found",
    "Biological Activity": [
      "Antiviral"
    ],
    "Target Organism": "Not found",
    "Hemolytic Activity": "Not found",
    "Cytotoxicity": "Not found",
    "Binding Target": "Not found",
    "Linear/Cyclic": "Not found",
    "N-terminal Modification": "Not found",
    "C-terminal Modification": "Not found",
    "Nonterminal Modifications and Unusual Amino Acids": "Not found",
    "Stereochemistry": "Not found",
    "Structure": "Unknown",
    "Structure Description": "Not found",
    "Helical Wheel Diagram": "Not found",
    "PDB ID": "",
    "Predicted Structure": "Not found",
    "Formula": "Not found",
    "Absent Amino Acids": "Not found",
    "Common Amino Acids": "Not found",
    "Mass": "Not found",
    "PI": "Not found",
    "Basic Residues": "Not found",
    "Acidic Residues": "Not found",
    "Hydrophobic Residues": "Not found",
    "Net charge": 6,
    "Boman Index": 4.05,
    "Hydrophobicity": "Not found",
    "Aliphatic Index": "Not found",
    "Half Life": "Not found",
    "Extinction Coefficient Cystines": "Not found",
    "Absorbance 280nm": "Not found",
    "Polar Residues": "Not found",
    "Function": "Not found",
    "Hydrophobic residue%": "31%",
    "Crucial residues": ""
  },
  "Literature Information": {
    "Literature": "Peptide design: WL-1 is a modified version of GF-17 by making the following changes F17W, V21K, F27K, and deleting V32.Sequence analysis: APD analysis reveals that this sequence shows similarity (76.47%) toGF-17K: 25%; R: 19%, I=L: 13%.Activity: inhibited herpes simplex virus 1 (HSV-1) infection in epithelial and neuronal cells.Animal model:mouse: beneficial treatment outcomes were observed in HSV-1 ear infected mice after WL-1 treatment.",
    "Author": "Guo X, An Y, Tan W, Ma L, Wang M, Li J, Li B, Hou W, Wu L. 2023",
    "Reference": "Front Microbiol. 2023 Jun 5;14:1201505. doi: 10.3389/fmicb.2023.1201505.PubMed",
    "Title": "Cathelicidin-derived antiviral peptide inhibits herpes simplex virus 1 infection."
  },
  "3D Structure": []
}